| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/2011 | EP2328888A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 06/08/2011 | EP2328872A1 Pyrazole compounds 436 |
| 06/08/2011 | EP2328866A1 3',6-substituted indirubins and their biological applications |
| 06/08/2011 | EP2328604A1 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 06/08/2011 | EP2328603A2 Derivatives of apf and methods of use |
| 06/08/2011 | EP2328600A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 06/08/2011 | EP2328579A1 Trioxane dimer sulfur compounds |
| 06/08/2011 | EP2328570A2 Method and formulation for treating adverse biological conditions |
| 06/08/2011 | EP2328555A2 Compositions for the treatment of neoplastic diseases |
| 06/08/2011 | EP2328554A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 06/08/2011 | EP2328412A1 Iap inhibitors |
| 06/08/2011 | EP2188290B1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 06/08/2011 | EP1948664B1 Pyrrolotriazine kinase inhibitors |
| 06/08/2011 | EP1919513B1 Targeted vector comprising a cyclodecapeptide RAFT and an activable imaging function |
| 06/08/2011 | EP1890683B1 Methods of supressing uv light-induced skin carcinogenesis |
| 06/08/2011 | EP1879895B1 Enzyme inhibitors |
| 06/08/2011 | EP1856043B1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer |
| 06/08/2011 | EP1809628B1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 06/08/2011 | EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/08/2011 | EP1531800B1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 06/08/2011 | EP1502599B1 Use of mutated VEGF for antiangiogenic therapy |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1392255B1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 06/08/2011 | EP0914142B1 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 06/08/2011 | CN1927877B siRNA for inhibiting human Ezrin gene expression and expression vector thereof |
| 06/08/2011 | CN1867564B Process for preparing amino crotonyl compounds |
| 06/08/2011 | CN1816544B Immunosuppressant compounds and compositions |
| 06/08/2011 | CN1784242B A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 06/08/2011 | CN1651451B 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application |
| 06/08/2011 | CN102089320A Lytic domain fusion constructs and methods of making and using same |
| 06/08/2011 | CN102089312A Salinosporamide derivatives as proteasome inhibitors |
| 06/08/2011 | CN102089309A Pyrrolobenzodiazepines |
| 06/08/2011 | CN102089308A PI3K isoform selective inhibitors |
| 06/08/2011 | CN102089307A Pyrrolopyridines as kinase inhibitors |
| 06/08/2011 | CN102089286A Chemical compounds |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089010A Dicabba-analogues of octreotide |
| 06/08/2011 | CN102089004A Pharmaceutical composition for treatment and prevention of cancer |
| 06/08/2011 | CN102089001A Immunity-inducing agent and method for detection of cancer |
| 06/08/2011 | CN102088985A Intestinal environment-improving agent |
| 06/08/2011 | CN102088983A Treatment of cancers of the blood using selected glycomimetic compounds |
| 06/08/2011 | CN102088982A Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine |
| 06/08/2011 | CN102088980A 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer |
| 06/08/2011 | CN102088979A Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin-4-yl] oxy}quinazoline |
| 06/08/2011 | CN102088974A Treatment of bladder diseases with a tlr7 activator |
| 06/08/2011 | CN102088973A Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 06/08/2011 | CN102088971A Use of tocotrienol composition for the prevention of cancer |
| 06/08/2011 | CN102088969A Combination of spacitabine (CNDAC) and DNA methyltransferase inhibitors such as decitabine and procaine |
| 06/08/2011 | CN102086453A Tumor DNA vaccine taking mucin 1 and survivin as targets and viral vector vaccine |
| 06/08/2011 | CN102086219A Anthracycline antibiotic simple analogues with anticancer activities and preparation method of analogues |
| 06/08/2011 | CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 06/08/2011 | CN102086207A Camptothecin derivative with antitumor activity |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102086182A Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 06/08/2011 | CN102086150A Seven-layer tower extract and extraction method thereof, and seven-layer tower extract-containing component |
| 06/08/2011 | CN102085378A Application of hfgl2 (Human Fibrinogen-like protein 2) inhibitor in preparation of medicaments for treating liver cancer |
| 06/08/2011 | CN102085377A Immunogenic composition and methods |
| 06/08/2011 | CN102085375A In-situ magnetically-heated temperature-sensitive targeted nano drug carrier for reversal of multi-drug resistance in tumors |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085361A Application of medicament containing hirudin and hementerin |
| 06/08/2011 | CN102085354A Polypeptide drug for treating tumors caused by human papilloma virus 16 (HPV-16) |
| 06/08/2011 | CN102085353A Polypeptide drug for treating tumors caused by human papilloma virus 18 (HPV-18) |
| 06/08/2011 | CN102085328A Medicament with anti-tumor effect and preparation method thereof |
| 06/08/2011 | CN102085307A Glabrous sarcandra herb drop pills |
| 06/08/2011 | CN102085293A Liriope muscari extract with anti-tumor action and preparation method thereof |
| 06/08/2011 | CN102085286A Traditional Chinese medicinal preparation for treating colon cancer and method for preparing same |
| 06/08/2011 | CN102085274A Traditional Chinese medicine composition for treating acute, chronic and subacute leukemia and preparation method thereof |
| 06/08/2011 | CN102085256A Immune regulation oral liquid preparation with anti-cancer efficacy and preparation method of a main component thereof |
| 06/08/2011 | CN102085251A Medicinal composition for treating hepatitis, tuberculosis and tumors and preparation method thereof |
| 06/08/2011 | CN102085245A Traditional Chinese medicine with functions of treating drug addiction, healing wounds and relieving cancer pain |
| 06/08/2011 | CN102085225A Method for extracting glaucescent fissistigma root saponins |
| 06/08/2011 | CN102085217A Pharmaceutical composition containing medicinal calcium salt for early preventing colorectal adenoma or colorectal cancer |
| 06/08/2011 | CN102085214A Low-molecular citrus pectin capable of being combined with clinical common chemotherapeutic drug for controlling cancer and cancer metastasis and diffusion |
| 06/08/2011 | CN102085206A Medicinal composition |
| 06/08/2011 | CN102085191A Anastrozole oral disintegrating tablet and preparation method thereof |
| 06/08/2011 | CN102085189A Docetaxel liposome sterile lyophilized preparation and preparation method thereof |
| 06/08/2011 | CN102085186A Glycyrrhetinic acid emulsion and preparation method thereof |
| 06/08/2011 | CN102085184A Preparation of fotemustine fat emulsion for injection |
| 06/08/2011 | CN102085177A Reducible and degradable nano medicine-carrying micelle and preparation method thereof |
| 06/08/2011 | CN101744800B Nedaplatin medical composition and application |
| 06/08/2011 | CN101708160B Pamidronate disodium suspension injection |
| 06/08/2011 | CN101659663B Indolizine derivative as well as preparation method and application thereof |
| 06/08/2011 | CN101623502B Preparation method of Ganodenic acid monomer Me cyclodextrin inclusion compound and of oral solid preparation |
| 06/08/2011 | CN101612119B Cucurbitacin solid lipid nanoparticle preparation and preparation method thereof |
| 06/08/2011 | CN101584802B Chinese medicinal capsule for treating malignant lymphoma |
| 06/08/2011 | CN101584661B Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof |
| 06/08/2011 | CN101584660B Intravenous injection perilla alcohol submicron emulsion and preparation method thereof |
| 06/08/2011 | CN101472581B Therapeutic or prophylactic agent for leukemia |
| 06/08/2011 | CN101456913B Anti-tumor fusion protein and use thereof |
| 06/08/2011 | CN101433592B Preparation method of Lupulus extract containing xanthohumol |
| 06/08/2011 | CN101433575B Chinese sapium bark seed extract and preparation method thereof |
| 06/08/2011 | CN101406486B Method for preparing maggot health-care oral liquid |
| 06/08/2011 | CN101367883B Method for extracting glossy ganoderma polysaccharide from fermentation liquor |
| 06/08/2011 | CN101337932B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 06/08/2011 | CN101209263B Medicine for treating tumor |
| 06/08/2011 | CN101190916B Anticancer compound, preparation method and use thereof, and composition containing the compound |
| 06/08/2011 | CN101139613B Antineoplastic dibasic polypeptide and application and preparation method thereof |
| 06/08/2011 | CN101084983B Traditional Chinese medicine powder injection for treating tumor and its preparation process |